Takhzyro Quick Start Program

Funded
About
The Takhzyro Quick Start Program offers immediate access to the Takhzyro medication at no cost, providing significant benefits for patients awaiting commercial insurance coverage approvals. This program is specifically tailored for individuals diagnosed with hereditary angioedema (HAE) aged 12 and older, ensuring that those with a valid prescription for Takhzyro and commercial insurance in the US can receive their medication with timely support.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Must be 18 years of age or older
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Takeda will provide eligible patients with immediate access to TAKHZYRO at no cost during potential delays in commercial insurance coverage determinations
Completed start form can be faxed to 18556637284
Patients should Contact a OnePath Patient Support Manager Monday through Friday, 8:30 am to 8:00 pm ET, at 1–866–888–0660 to find out more
Other Programs

Accessia Health: Hereditary Angioedema - Private Insurance

Commercially Insured
Underinsured
Uninsured
Max Saving: $9500/year*

Accessia Health: Hereditary Angioedema - Public Insurance

Medicare / Medicaid
Max Saving: $7500/year*
Other Tools for Takhzyro